SCHEMBL19616976

SCHEMBL19616976

C[C@H]1c2nc(Cl)nc(N3CCN(C(=O)OC(C)(C)C)CC3)c2CCN1Cc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.44
CKS1B P61024 2/20 0.43
SKP1 P63208 2/20 0.43
SKP2 Q13309 2/20 0.43
TLR9 Q9NR96 3/20 0.43
GBA1 P04062 2/20 0.43
TLR7 Q9NYK1 2/20 0.43
SCD O00767 1/20 0.42
SCD5 Q86SK9 1/20 0.42
KIT P10721 1/20 0.42
OPRD1 P41143 1/20 0.40
OPRK1 P41145 1/20 0.40
GPR119 Q8TDV5 2/20 0.39
TP53 P04637 1/20 0.39
THRB P10828 1/20 0.39
P2RX7 Q99572 1/20 0.39
PDE10A Q9Y233 1/20 0.39
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39
STS P08842 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19948152 1.00 ACHE (0.44) ACHECKS1BSKP1SKP2TLR9
SCHEMBL19617700 0.88 CFTR (0.36) TP53
SCHEMBL30675362 0.85 OPRD1 (0.42) OPRD1OPRK1
SCHEMBL19948723 0.84 TLR9 (0.43) ACHECKS1BSKP1SKP2TLR9
SCHEMBL19616667 0.84 TLR9 (0.43) ACHECKS1BSKP1SKP2TLR9
SCHEMBL19947889 0.82 ACHE (0.44) ACHECKS1BSKP1SKP2TLR9
SCHEMBL19616949 0.82 ACHE (0.44) ACHECKS1BSKP1SKP2TLR9
SCHEMBL23074865 0.81 C5AR1 (0.48) ACHECKS1BSKP1SKP2TLR9
SCHEMBL19948150 0.80 SLC6A7 (0.37)
SCHEMBL19616741 0.80 C5AR1 (0.47) ACHECKS1BSKP1SKP2TLR9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3710439-A1 KRAS G12C INHIBITORS Mirati Therapeutics, Inc. (US) 2020-09-23 EP disclosed
EP-3458445-A1 KRAS G12C INHIBITORS Mirati Therapeutics, Inc. (US) 2019-03-27 EP disclosed
WO-2017201161-A1 KRAS G12C INHIBITORS Mirati Therapeutics, Inc. (US) 2017-11-23 WO disclosed